TGFB1 and neoplasm: In this context, MSCs have been shown to promote tumor progression by inhibiting the release of pro-inflammatory cytokines and increasing the generation of M2-like macrophage through the secretion of a variety of immunomodulatory molecules such as PGE2, IL1RA, TGF-β, and IL-8 (32, 131).